Sign in

CIK 0001580149

  • Non-accelerated filer
  • Smaller reporting company

BIOVIE INC.

Sign in to watch
Ticker
BIVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
462510769
Phone
+1 775-888-3162
Business address
680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
Former names
NANOANTIBIOTICS, INC.

Securities

  • BIVI Common stock Nasdaq
  • BIVIW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 33,952 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 23,202 shares (to pay taxes)
  8. 4 Shares withheld for taxes President & CEO gave up 51,906 shares (to pay taxes)
  9. 4 Open-market buy President & CEO bought 10,000 shares
  10. 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Director sold 75,680 shares at $1.69 ($127,899)
  13. 4 Grant or award Director acquired 42,254 shares (grant or award)
  14. 4 Grant or award Director acquired 42,254 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 51,830 shares (grant or award)
  17. 4 Open-market buy President & CEO bought 10,000 shares at $1.78 ($17,800)
  18. 4 Open-market sale Director sold 8,560 shares at $3.05 ($26,108)
  19. 4 Open-market sale Director sold 10,805 shares at $3.50 ($37,827)
  20. 4 Derivatives Options or other derivatives

Page 2 of 8 · 147 filings